TP53 and cancer: Whole-body MRI is recommended once per year from birth for carriers of especially high-cancer-risk TP53 variants, defined as variants associated with childhood cancers in the index case or family, or those corresponding to dominant-negative missense variants, or in individuals with a prior history of chemotherapy or radiotherapy.